4-(4-(thiophen-3-yl)pyrimidin-2-ylamino)benzenesulfonamide

ID: ALA1084970

PubChem CID: 46890318

Max Phase: Preclinical

Molecular Formula: C14H12N4O2S2

Molecular Weight: 332.41

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  NS(=O)(=O)c1ccc(Nc2nccc(-c3ccsc3)n2)cc1

Standard InChI:  InChI=1S/C14H12N4O2S2/c15-22(19,20)12-3-1-11(2-4-12)17-14-16-7-5-13(18-14)10-6-8-21-9-10/h1-9H,(H2,15,19,20)(H,16,17,18)

Standard InChI Key:  JUIXZPWSSOKEIF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
    3.0167    0.9722    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4340    0.2546    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.8468    0.9747    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8515   -1.4089    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1340   -0.9949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1369   -0.1632    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8533    0.2464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5821   -1.4069    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2969   -0.9927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0097   -1.4051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7240   -0.9916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7232   -0.1645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0020    0.2472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2906   -0.1686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1541   -0.1603    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2798   -1.4105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5637   -1.0009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5581   -0.1718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0277   -1.0691    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5823   -1.6799    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1726   -2.3961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3650   -2.2277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 10 11  1  0
  5  6  1  0
 11 12  2  0
 12 13  1  0
  6  7  2  0
 13 14  2  0
 14  9  1  0
 12  2  1  0
  7 18  1  0
  2 15  1  0
 17  4  1  0
  5  8  1  0
  2  1  2  0
 16 17  1  0
 17 18  2  0
 16 19  2  0
  8  9  1  0
  4  5  2  0
  9 10  2  0
  3  2  2  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 16  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA1084970

   4-(4-(Thiophen-3-yl)pyrimidin-2-ylamino)benzenesulfonamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 332.41

Molecular Weight (Monoisotopic): 332.0402

AlogP: 2.60

#Rotatable Bonds: 4

Polar Surface Area: 97.97

Molecular Species: NEUTRAL

HBA: 6

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 10.67

CX Basic pKa: 1.47

CX LogP: 2.59

CX LogD: 2.59

Aromatic Rings: 3

Heavy Atoms: 22

QED Weighted: 0.77

Np Likeness Score: -2.34

References

1. Crombie AL, Sum FW, Powell DW, Hopper DW, Torres N, Berger DM, Zhang Y, Gavriil M, Sadler TM, Arndt K..  (2010)  Synthesis and biological evaluation of tricyclic anilinopyrimidines as IKKbeta inhibitors.,  20  (12): [PMID:20471256] [10.1016/j.bmcl.2010.04.022]

Source

Source(1):

• Scientific Literature